Overexpression	O
of	O
DR-nm23	B-protein
,	O
a	O
protein	O
encoded	O
by	O
a	O
member	O
of	O
the	O
nm23	B-DNA
gene	I-DNA
family	I-DNA
,	O
inhibits	O
granulocyte	B-cell_type
differentiation	O
and	O
induces	O
apoptosis	O
in	O
32Dc13	B-cell_line
myeloid	I-cell_line
cells	I-cell_line
.	O

Chronic	O
myelogenous	O
leukemia	O
evolves	O
in	O
two	O
clinically	O
distinct	O
stages	O
:	O
a	O
chronic	O
and	O
a	O
blast	O
crisis	O
phase	O
.	O

The	O
molecular	O
changes	O
associated	O
with	O
chronic	O
phase	O
to	O
blast	O
crisis	O
transition	O
are	O
largely	O
unknown	O
.	O

We	O
have	O
identified	O
a	O
cDNA	B-DNA
clone	I-DNA
,	O
DR-nm23	B-protein
,	O
differentially	O
expressed	O
in	O
a	O
blast-crisis	B-DNA
cDNA	I-DNA
library	I-DNA
,	I-DNA
which	O
has	O
approximately	O
70	O
%	O
sequence	O
similarity	O
to	O
the	O
putative	B-DNA
metastatic	I-DNA
suppressor	I-DNA
genes	I-DNA
,	O
nm23-H1	B-DNA
and	O
nm23-H2	B-DNA
.	O

The	O
deduced	O
amino	O
acid	O
sequence	O
similarity	O
to	O
the	O
proteins	O
encoded	O
by	O
these	O
two	O
latter	O
genes	O
is	O
approximately	O
65	O
%	O
and	O
includes	O
domains	O
and	O
amino	O
acid	O
residues	O
(	O
the	O
leucine	B-protein
zipper-like	I-protein
and	O
the	O
RGD	B-protein
domain	I-protein
,	O
a	O
serine	O
and	O
a	O
histidine	O
residue	O
in	O
the	O
NH2-	B-protein
and	O
in	O
the	O
COOH-terminal	B-protein
portion	I-protein
of	O
the	O
protein	O
,	O
respectively	O
)	O
postulated	O
to	O
be	O
important	O
for	O
nm23	B-protein
function	O
.	O

DR-nm23	B-RNA
mRNA	I-RNA
is	O
preferentially	O
expressed	O
at	O
early	O
stages	O
of	O
myeloid	O
differentiation	O
of	O
highly	B-cell_line
purified	I-cell_line
CD34+	I-cell_line
cells	I-cell_line
.	O

Its	O
constitutive	O
expression	O
in	O
the	O
myeloid	B-cell_line
precursor	I-cell_line
32Dc13	I-cell_line
cell	I-cell_line
line	I-cell_line
,	O
which	O
is	O
growth-factor	O
dependent	O
for	O
both	O
proliferation	O
and	O
differentiation	O
,	O
results	O
in	O
inhibition	O
of	O
granulocytic	O
differentiation	O
induced	O
by	O
granulocyte	B-protein
colony-stimulating	I-protein
factor	I-protein
and	O
causes	O
apoptotic	O
cell	O
death	O
.	O

These	O
results	O
are	O
consistent	O
with	O
a	O
role	O
for	O
DR-nm23	B-protein
in	O
normal	O
hematopoiesis	O
and	O
raise	O
the	O
possibility	O
that	O
its	O
overexpression	O
contributes	O
to	O
differentiation	O
arrest	O
,	O
a	O
feature	O
of	O
blastic	O
transformation	O
in	O
chronic	O
myelogenous	O
leukemia	O
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

92	NULL
,	NULL
pp	NULL
.	NULL

7435-7439	NULL
,	NULL
August	NULL
1995	NULL
Medical	NULL
Sciences	NULL
Overexpression	NULL
of	NULL
DR-nm23	NULL
,	NULL
a	NULL
protein	NULL
encoded	NULL
by	NULL
a	NULL
member	NULL
of	NULL
the	NULL
n	NULL
»	NULL
m23	NULL
gene	NULL
family	NULL
,	NULL
inhibits	NULL
granulocyte	NULL
differentiation	NULL
and	NULL
induces	NULL
apoptosis	NULL
in	NULL
32Dc13	NULL
myeloid	NULL
cells	NULL
DoNATELLA	NULL
VentTurELLI*T	NULL
,	NULL
RoBERT	NULL
MARTINEZ*T	NULL
,	NULL
PaoLa	NULL
MELOTTI*	NULL
,	NULL
IDA	NULL
CASELLA*	NULL
,	NULL
CESARE	NULL
PESCHLE*	NULL
,	NULL
CARLA	NULL
CUCCO®*	NULL
,	NULL
GIUSEPPINA	NULL
SPAMPINATO*	NULL
,	NULL
ZBIGNIEW	NULL
AND	NULL
BRUNO	NULL
CALABRETTA*	NULL
*Thomas	NULL
Jefferson	NULL
University	NULL
,	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
Jefferson	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bluemle	NULL
Life	NULL
Sciences	NULL
Building	NULL
,	NULL
233	NULL
South	NULL
10th	NULL
Street	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
19107	NULL
;	NULL
and	NULL
*The	NULL
Cancer	NULL
Research	NULL
Institute	NULL
,	NULL
New	NULL
York	NULL
Medical	NULL
College	NULL
,	NULL
Elmsford	NULL
,	NULL
NY	NULL
10523	NULL
Communicated	NULL
by	NULL
Sidney	NULL
Weinhouse	NULL
,	NULL
Thomas	NULL
Jefferson	NULL
University	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
,	NULL
April	NULL
12	NULL
,	NULL
1995	NULL
ABSTRACT	NULL
Chronic	NULL
myelogenous	NULL
leukemia	NULL
evolves	NULL
in	NULL
two	NULL
clinically	NULL
distinct	NULL
stages	NULL
:	NULL
a	NULL
chronic	NULL
and	NULL
a	NULL
blast	NULL
crisis	NULL
phase	NULL
.	NULL

The	NULL
molecular	NULL
changes	NULL
associated	NULL
with	NULL
chronic	NULL
phase	NULL
to	NULL
blast	NULL
crisis	NULL
transition	NULL
are	NULL
largely	NULL
unknown	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
a	NULL
cDNA	NULL
clone	NULL
,	NULL
DR-nm23	NULL
,	NULL
differentially	NULL
expressed	NULL
in	NULL
a	NULL
blast-crisis	NULL
cDNA	NULL
library	NULL
,	NULL
which	NULL
has	NULL
~70	NULL
%	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
putative	NULL
metastatic	NULL
suppressor	NULL
genes	NULL
,	NULL
nm23-H1	NULL
and	NULL
nm23-H2	NULL
.	NULL

The	NULL
deduced	NULL
amino	NULL
acid	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
proteins	NULL
encoded	NULL
by	NULL
these	NULL
two	NULL
latter	NULL
genes	NULL
is	NULL
~65	NULL
%	NULL
and	NULL
includes	NULL
domains	NULL
and	NULL
amino	NULL
acid	NULL
residues	NULL
(	NULL
the	NULL
leucine	NULL
zipper-like	NULL
and	NULL
the	NULL
RGD	NULL
domain	NULL
,	NULL
a	NULL
serine	NULL
and	NULL
a	NULL
histidine	NULL
residue	NULL
in	NULL
the	NULL
NH	NULL
;	NULL
-	NULL
and	NULL
in	NULL
the	NULL
COOH-terminal	NULL
portion	NULL
of	NULL
the	NULL
protein	NULL
,	NULL
respectively	NULL
)	NULL
postulated	NULL
to	NULL
be	NULL
important	NULL
for	NULL
nm23	NULL
function	NULL
.	NULL

DR-nm23	NULL
mRNA	NULL
is	NULL
preferentially	NULL
expressed	NULL
at	NULL
early	NULL
stages	NULL
of	NULL
myeloid	NULL
differentiation	NULL
of	NULL
highly	NULL
purified	NULL
CD34+*	NULL
cells	NULL
.	NULL

Its	NULL
constitutive	NULL
expression	NULL
in	NULL
the	NULL
myeloid	NULL
precursor	NULL
32Dc13	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
is	NULL
growth-factor	NULL
dependent	NULL
for	NULL
both	NULL
proliferation	NULL
and	NULL
differentiation	NULL
,	NULL
results	NULL
in	NULL
inhibition	NULL
of	NULL
granulocytic	NULL
differentiation	NULL
induced	NULL
by	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
causes	NULL
apoptotic	NULL
cell	NULL
death	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
role	NULL
for	NULL
DR-nm23	NULL
in	NULL
normal	NULL
hematopoiesis	NULL
and	NULL
raise	NULL
the	NULL
possibility	NULL
that	NULL
its	NULL
overexpression	NULL
contributes	NULL
to	NULL
differentiation	NULL
arrest	NULL
,	NULL
a	NULL
feature	NULL
of	NULL
blastic	NULL
transformation	NULL
in	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
.	NULL

Hematopoiesis	NULL
is	NULL
a	NULL
regulated	NULL
developmental	NULL
cascade	NULL
that	NULL
generates	NULL
at	NULL
least	NULL
eight	NULL
distinct	NULL
lineages	NULL
that	NULL
differentiate	NULL
into	NULL
mature	NULL
blood	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Central	NULL
to	NULL
the	NULL
process	NULL
are	NULL
pluripotent	NULL
stem	NULL
cells	NULL
which	NULL
generate	NULL
multipotent	NULL
and	NULL
unipotent	NULL
progenitor	NULL
cells	NULL
,	NULL
whose	NULL
continuous	NULL
regeneration	NULL
is	NULL
essential	NULL
to	NULL
hematopoietic	NULL
homeostasis	NULL
.	NULL

Chronic	NULL
myelogenous	NULL
leukemia	NULL
(	NULL
CML	NULL
)	NULL
is	NULL
a	NULL
malignancy	NULL
of	NULL
the	NULL
human	NULL
hematopoietic	NULL
stem	NULL
cell	NULL
characterized	NULL
by	NULL
the	NULL
Philadelphia	NULL
chromosome	NULL
(	NULL
Ph	NULL
)	NULL
(	NULL
2	NULL
)	NULL
and	NULL
,	NULL
at	NULL
the	NULL
molecular	NULL
level	NULL
,	NULL
juxtaposition	NULL
of	NULL
5	NULL
'	NULL
coding	NULL
sequences	NULL
of	NULL
the	NULL
breakpoint	NULL
cluster	NULL
region	NULL
(	NULL
ber	NULL
)	NULL
gene	NULL
on	NULL
chromosome	NULL
22	NULL
and	NULL
3	NULL
'	NULL
coding	NULL
sequences	NULL
of	NULL
the	NULL
c-abl	NULL
gene	NULL
on	NULL
chromosome	NULL
9	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Clinically	NULL
,	NULL
CML	NULL
presents	NULL
initially	NULL
as	NULL
a	NULL
chronic	NULL
phase	NULL
characterized	NULL
by	NULL
an	NULL
increased	NULL
number	NULL
of	NULL
immature	NULL
myeloid	NULL
precursor	NULL
cells	NULL
which	NULL
retain	NULL
the	NULL
ability	NULL
to	NULL
terminally	NULL
differentiate	NULL
.	NULL

Three	NULL
to	NULL
five	NULL
years	NULL
after	NULL
diagnosis	NULL
,	NULL
CML	NULL
usually	NULL
progresses	NULL
first	NULL
to	NULL
an	NULL
accelerated	NULL
phase	NULL
with	NULL
a	NULL
duration	NULL
of	NULL
1-1.5	NULL
years	NULL
and	NULL
then	NULL
into	NULL
a	NULL
rapidly	NULL
fatal	NULL
blastic	NULL
phase	NULL
,	NULL
characterized	NULL
by	NULL
growth	NULL
advantage	NULL
and	NULL
differentiation	NULL
arrest	NULL
of	NULL
CML	NULL
blast	NULL
cells	NULL
.	NULL

Although	NULL
the	NULL
prognostic	NULL
factors	NULL
associated	NULL
with	NULL
the	NULL
disease	NULL
process	NULL
are	NULL
better	NULL
known	NULL
than	NULL
in	NULL
the	NULL
past	NULL
(	NULL
4	NULL
)	NULL
,	NULL
the	NULL
molecular	NULL
mechanisms	NULL
involved	NULL
in	NULL
chronic	NULL
phase	NULL
to	NULL
blast	NULL
transition	NULL
remain	NULL
elusive	NULL
.	NULL

The	NULL
objective	NULL
of	NULL
the	NULL
work	NULL
described	NULL
here	NULL
was	NULL
the	NULL
identification	NULL
of	NULL
genes	NULL
which	NULL
may	NULL
have	NULL
a	NULL
pathogenetic	NULL
role	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

7435	NULL
in	NULL
this	NULL
transition	NULL
.	NULL

To	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
selected	NULL
by	NULL
differential	NULL
screening	NULL
cDNA	NULL
clones	NULL
preferentially	NULL
expressed	NULL
in	NULL
CML-blast	NULL
crisis	NULL
(	NULL
CML-BC	NULL
)	NULL
cells	NULL
.	NULL

One	NULL
such	NULL
gene	NULL
,	NULL
related	NULL
to	NULL
members	NULL
of	NULL
the	NULL
nm23	NULL
tumor	NULL
suppressor	NULL
gene	NULL
family	NULL
,	NULL
appears	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
hematopoiesis	NULL
and	NULL
perhaps	NULL
in	NULL
leukemogenesis	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
its	NULL
ability	NULL
,	NULL
when	NULL
overexpressed	NULL
,	NULL
to	NULL
suppress	NULL
granulocytic	NULL
differentiation	NULL
of	NULL
myeloid	NULL
precursor	NULL
32Dc13	NULL
cells	NULL
.	NULL

$	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Screening	NULL
of	NULL
a	NULL
CML-BC	NULL
cDNA	NULL
Library	NULL
.	NULL

A	NULL
CML-BC	NULL
cDNA	NULL
library	NULL
was	NULL
prepared	NULL
in	NULL
the	NULL
pcDNA	NULL
I	NULL
vector	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Gubler	NULL
and	NULL
Hoffman	NULL
(	NULL
5	NULL
)	NULL
and	NULL
manufacturer	NULL
's	NULL
modifications	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
2	NULL
x	NULL
10°	NULL
colonies	NULL
of	NULL
the	NULL
CML-BC	NULL
cDNA	NULL
library	NULL
were	NULL
screened	NULL
by	NULL
differential	NULL
hybridization	NULL
of	NULL
replicate	NULL
filters	NULL
(	NULL
6	NULL
)	NULL
with	NULL
*P-labeled	NULL
cDNA	NULL
probes	NULL
(	NULL
2	NULL
x	NULL
10°/ml	NULL
)	NULL
generated	NULL
by	NULL
reverse	NULL
transcription	NULL
of	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
from	NULL
either	NULL
the	NULL
CCRF-CEM	NULL
cell	NULL
line	NULL
or	NULL
CML-BC	NULL
primary	NULL
cells	NULL
.	NULL

Differentially	NULL
hybridizing	NULL
clones	NULL
were	NULL
subjected	NULL
to	NULL
two	NULL
additional	NULL
rounds	NULL
of	NULL
differential	NULL
screening	NULL
.	NULL

One	NULL
clone	NULL
(	NULL
clone	NULL
126	NULL
)	NULL
was	NULL
identified	NULL
and	NULL
characterized	NULL
.	NULL

DNA	NULL
Sequencing	NULL
.	NULL

Double-stranded	NULL
DNA	NULL
sequencing	NULL
of	NULL
plasmid	NULL
DNA	NULL
was	NULL
performed	NULL
with	NULL
Sequenase	NULL
(	NULL
United	NULL
States	NULL
Biochemical	NULL
)	NULL
and	NULL
synthetic	NULL
oligonucleotide	NULL
primers	NULL
by	NULL
the	NULL
dideoxynucleotide	NULL
chain-termination	NULL
method	NULL
.	NULL

RNA	NULL
Preparation	NULL
and	NULL
Northern	NULL
Blot	NULL
Analysis	NULL
.	NULL

Total	NULL
RNA	NULL
extracted	NULL
by	NULL
the	NULL
guanidinium	NULL
isothiocyanate/cesium	NULL
chloride	NULL
method	NULL
(	NULL
7	NULL
)	NULL
was	NULL
electrophoresed	NULL
(	NULL
20	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
through	NULL
1.2	NULL
%	NULL
agarose	NULL
gels	NULL
containing	NULL
0.66	NULL
M	NULL
formaldehyde	NULL
and	NULL
Mops	NULL
buffer	NULL
(	NULL
40	NULL
mM	NULL
Mops	NULL
,	NULL
pH	NULL
7.2/10	NULL
mM	NULL
sodium	NULL
acetate	NULL
mM	NULL
EDTA	NULL
)	NULL
and	NULL
blotted	NULL
onto	NULL
Zetabind	NULL
membrane	NULL
(	NULL
Cuno	NULL
)	NULL
.	NULL

Clone	NULL
126	NULL
insert	NULL
or	NULL
the	NULL
full-length	NULL
cDNA	NULL
(	NULL
see	NULL
below	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
after	NULL
random	NULL
primer	NULL
labeling	NULL
with	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Cloning	NULL
of	NULL
Full-Length	NULL
DR-nm23	NULL
.	NULL

DR-nm23	NULL
,	NULL
identified	NULL
as	NULL
a	NULL
sequence	NULL
(	NULL
clone	NULL
126	NULL
)	NULL
that	NULL
is	NULL
differentially	NULL
expressed	NULL
in	NULL
CML-BC	NULL
cells	NULL
relative	NULL
to	NULL
CCRF-CEM	NULL
cells	NULL
,	NULL
contained	NULL
an	NULL
insert	NULL
of	NULL
652	NULL
bp	NULL
that	NULL
lacked	NULL
the	NULL
initiation	NULL
codon	NULL
and	NULL
was	NULL
shorter	NULL
than	NULL
the	NULL
corresponding	NULL
RNA	NULL
transcripts	NULL
detected	NULL
by	NULL
Northern	NULL
blot	NULL
hybridization	NULL
.	NULL

The	NULL
full-length	NULL
cDNA	NULL
was	NULL
cloned	NULL
in	NULL
four	NULL
successive	NULL
steps	NULL
:	NULL
(	NULL
?	NULL
)	NULL

a	NULL
K562	NULL
cDNA	NULL
library	NULL
in	NULL
Agt1l0	NULL
was	NULL
screened	NULL
to	NULL
identify	NULL
additional	NULL
DR-nm23	NULL
clones	NULL
;	NULL
(	NULL
i	NULL
)	NULL
after	NULL
identification	NULL
of	NULL
several	NULL
positive	NULL
clones	NULL
,	NULL
the	NULL
longest	NULL
EcoRI	NULL
insert	NULL
(	NULL
820	NULL
bp	NULL
)	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
EcoRI	NULL
restriction	NULL
site	NULL
of	NULL
pBluescript	NULL
SK	NULL
plasmid	NULL
vector	NULL
(	NULL
Stratagene	NULL
)	NULL
and	NULL
named	NULL
pDR-12	NULL
.	NULL

Sequence	NULL
analysis	NULL
revealed	NULL
that	NULL
it	NULL
was	NULL
still	NULL
lacking	NULL
the	NULL
region	NULL
around	NULL
the	NULL
initiation	NULL
codon	NULL
;	NULL
(	NULL
ii	NULL
?	NULL
)	NULL

to	NULL
reconstitute	NULL
the	NULL
remaining	NULL
5	NULL
'	NULL
segment	NULL
,	NULL
a	NULL
human	NULL
pla-	NULL
Abbreviations	NULL
:	NULL
CML	NULL
,	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
;	NULL
HA	NULL
,	NULL
hemagglu-	NULL
tinin	NULL
;	NULL
IL-3	NULL
,	NULL
interleukin	NULL
3	NULL
;	NULL
G-CSF	NULL
,	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
CML-BC	NULL
,	NULL
CML-blast	NULL
crisis	NULL
.	NULL

TD.V	NULL
.	NULL

and	NULL
R.M	NULL
.	NULL

contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

$	NULL
The	NULL
sequence	NULL
reported	NULL
in	NULL
this	NULL
paper	NULL
has	NULL
been	NULL
deposited	NULL
in	NULL
the	NULL
GenBank	NULL
data	NULL
base	NULL
(	NULL
accession	NULL
no	NULL
.	NULL

U29656	NULL
)	NULL
.	NULL

7436	NULL
Medical	NULL
Sciences	NULL
:	NULL
Venturelli	NULL
et	NULL
al	NULL
.	NULL

cental	NULL
genomic	NULL
library	NULL
in	NULL
Lambda	NULL
FIX	NULL
II	NULL
(	NULL
Stratagene	NULL
)	NULL
was	NULL
screened	NULL
with	NULL
a	NULL
P-labeled	NULL
insert	NULL
of	NULL
DR-nm23	NULL
.	NULL

Clone	NULL
1	NULL
contained	NULL
the	NULL
entire	NULL
coding	NULL
region	NULL
of	NULL
DR-nm23	NULL
within	NULL
a	NULL
BamHI-Not	NULL
1	NULL
1450-bp	NULL
fragment	NULL
;	NULL
(	NULL
iv	NULL
)	NULL
clone	NULL
DR-12	NULL
was	NULL
digested	NULL
with	NULL
EcoRI	NULL
to	NULL
release	NULL
the	NULL
820-bp	NULL
insert	NULL
.	NULL

This	NULL
insert	NULL
was	NULL
then	NULL
digested	NULL
with	NULL
Mbo	NULL
II	NULL
and	NULL
an	NULL
804-bp	NULL
fragment	NULL
was	NULL
isolated	NULL
.	NULL

The	NULL
genomic	NULL
BamHI-Not	NULL
I	NULL
insert	NULL
from	NULL
clone	NULL
1	NULL
was	NULL
digested	NULL
with	NULL
Mbo	NULL
II	NULL
and	NULL
a	NULL
45-bp	NULL
fragment	NULL
was	NULL
isolated	NULL
.	NULL

This	NULL
45-bp	NULL
fragment	NULL
was	NULL
then	NULL
ligated	NULL
via	NULL
a	NULL
triple-component	NULL
ligation	NULL
with	NULL
the	NULL
804-bp	NULL
fragment	NULL
into	NULL
the	NULL
BamHI-	NULL
and	NULL
EcoRI-digested	NULL
pBluescript	NULL
SK	NULL
vector	NULL
.	NULL

The	NULL
resulting	NULL
clones	NULL
,	NULL
designated	NULL
DR-9	NULL
and	NULL
DR-11	NULL
,	NULL
were	NULL
sequenced	NULL
and	NULL
shown	NULL
to	NULL
contain	NULL
the	NULL
full-length	NULL
cDNA	NULL
with	NULL
an	NULL
ATG	NULL
initiation	NULL
codon	NULL
and	NULL
an	NULL
in-frame	NULL
TAG	NULL
stop	NULL
codon	NULL
.	NULL

Cloning	NULL
of	NULL
pLXSN-DR-nm23	NULL
.	NULL

For	NULL
cloning	NULL
into	NULL
mammalian	NULL
expression	NULL
vectors	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
of	NULL
the	NULL
full-length	NULL
DR-nm23	NULL
cDNA	NULL
was	NULL
removed	NULL
by	NULL
Rsa	NULL
I	NULL
digestion	NULL
.	NULL

The	NULL
resulting	NULL
698-bp	NULL
fragment	NULL
was	NULL
blunt-ended	NULL
and	NULL
ligated	NULL
to	NULL
plasmid	NULL
pLXSN	NULL
(	NULL
9	NULL
)	NULL
,	NULL
digested	NULL
with	NULL
Xho	NULL
I	NULL
,	NULL
and	NULL
then	NULL
blunt-ended	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
.	NULL

The	NULL
resulting	NULL
plasmid	NULL
,	NULL
designated	NULL
pLXSN-DR-nm23	NULL
,	NULL
also	NULL
confers	NULL
resistance	NULL
to	NULL
the	NULL
antibiotic	NULL
G418	NULL
.	NULL

Cloning	NULL
of	NULL
Hemagglutinin	NULL
(	NULL
HA	NULL
)	NULL
-Tagged	NULL
DR-nm23	NULL
.	NULL

The	NULL
full-length	NULL
DR-nm23	NULL
cDNA	NULL
was	NULL
excised	NULL
by	NULL
digestion	NULL
of	NULL
the	NULL
pBluescript	NULL
SK	NULL
plasmid	NULL
first	NULL
with	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
and	NULL
then	NULL
with	NULL
Bsr	NULL
I	NULL
,	NULL
generating	NULL
two	NULL
fragments	NULL
(	NULL
499	NULL
and	NULL
365	NULL
nt	NULL
,	NULL
respec-tively	NULL
)	NULL
,	NULL
the	NULL
longer	NULL
of	NULL
which	NULL
contained	NULL
most	NULL
of	NULL
DR-nm23	NULL
coding	NULL
region	NULL
.	NULL

Oligonucleotides	NULL
(	NULL
F	NULL
,	NULL
5-TGTATGAGCAGG	NULL
,	NULL
and	NULL
G	NULL
,	NULL
5'-AATTCCTGCTCATACAGC	NULL
)	NULL
not	NULL
including	NULL
the	NULL
TAG	NULL
stop	NULL
codon	NULL
,	NULL
which	NULL
was	NULL
replaced	NULL
by	NULL
CAG	NULL
,	NULL
were	NULL
annealed	NULL
to	NULL
yield	NULL
a	NULL
double-stranded	NULL
DNA	NULL
oligomer	NULL
flanked	NULL
by	NULL
Bsr	NULL
I	NULL
and	NULL
EcoRI	NULL
recognition	NULL
sequence	NULL
overhangs	NULL
.	NULL

Recombinant	NULL
DR-nm23	NULL
devoid	NULL
of	NULL
the	NULL
TAG	NULL
codon	NULL
was	NULL
generated	NULL
by	NULL
ligation	NULL
of	NULL
the	NULL
annealed	NULL
primers	NULL
with	NULL
the	NULL
499-bp	NULL
fragment	NULL
into	NULL
a	NULL
Bam	NULL
HI-	NULL
and	NULL
EcoRI-digested	NULL
pBluescript	NULL
SK	NULL
plasmid	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
designated	NULL
pSKDR-nm23mutC	NULL
.	NULL

From	NULL
plasmid	NULL
pSKA-myb	NULL
5	NULL
HA3	NULL
(	NULL
10	NULL
)	NULL
,	NULL
the	NULL
triple	NULL
HA	NULL
epitope	NULL
was	NULL
excised	NULL
by	NULL
digestion	NULL
with	NULL
Xho	NULL
I	NULL
and	NULL
Sal	NULL
I	NULL
and	NULL
inserted	NULL
in	NULL
the	NULL
Xho	NULL
I	NULL
recognition	NULL
site	NULL
of	NULL
pSKDR-nm23mutC	NULL
.	NULL

To	NULL
maintain	NULL
the	NULL
construct	NULL
in	NULL
frame	NULL
,	NULL
an	NULL
extra	NULL
nucleotide	NULL
was	NULL
inserted	NULL
by	NULL
PCR	NULL
.	NULL

A	NULL
5°	NULL
primer	NULL
(	NULL
5'-GTCGACCTCGAGGCCACCATGG-3	NULL
'	NULL
)	NULL
and	NULL
the	NULL
T7	NULL
RNA	NULL
polymerase	NULL
promoter	NULL
site	NULL
primer	NULL
were	NULL
used	NULL
on	NULL
the	NULL
template	NULL
plasmid	NULL
pSKDR-nm23mutC	NULL
to	NULL
generate	NULL
a	NULL
163-bp	NULL
product	NULL
.	NULL

This	NULL
was	NULL
cleaved	NULL
with	NULL
Xho	NULL
I	NULL
and	NULL
Kpn	NULL
I	NULL
and	NULL
inserted	NULL
into	NULL
Xho	NULL
I-	NULL
and	NULL
Kpn	NULL
I-digested	NULL
pSKDR-nm23mutC	NULL
.	NULL

The	NULL
reading	NULL
frame	NULL
was	NULL
verified	NULL
by	NULL
sequencing	NULL
.	NULL

This	NULL
construct	NULL
was	NULL
called	NULL
pSKDR-nm23HA3	NULL
.	NULL

Cell	NULL
Culture	NULL
and	NULL
Primary	NULL
Cells	NULL
.	NULL

The	NULL
murine	NULL
interleukin	NULL
3	NULL
(	NULL
IL-3	NULL
)	NULL
-dependent	NULL
myeloid	NULL
cell	NULL
line	NULL
32Dc13	NULL
(	NULL
11	NULL
)	NULL
was	NULL
used	NULL
.	NULL

For	NULL
proliferation	NULL
studies	NULL
,	NULL
5	NULL
%	NULL
104	NULL
cells	NULL
per	NULL
ml	NULL
were	NULL
plated	NULL
in	NULL
4	NULL
ml	NULL
of	NULL
Iscove	NULL
's	NULL
modified	NULL
Dulbecco	NULL
's	NULL
medium	NULL
(	NULL
IMDM	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
heat-inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
and	NULL
15	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
WEHI	NULL
(	NULL
IL-3	NULL
producer	NULL
)	NULL
conditioned	NULL
medium	NULL
.	NULL

For	NULL
differentiation	NULL
studies	NULL
,	NULL
2.5	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
were	NULL
plated	NULL
in	NULL
4	NULL
ml	NULL
of	NULL
IMDM	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
conditioned	NULL
medium	NULL
from	NULL
the	NULL
U8S7MG	NULL
[	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
G-CSF	NULL
)	NULL
producer	NULL
]	NULL
cell	NULL
line	NULL
.	NULL

Human	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
were	NULL
purified	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
healthy	NULL
donors	NULL
by	NULL
a	NULL
four-step	NULL
procedure	NULL
(	NULL
12	NULL
)	NULL
and	NULL
cultured	NULL
as	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Detection	NULL
of	NULL
DR-nm23	NULL
and	NULL
Myeloperoxidase	NULL
mRNAs	NULL
in	NULL
CD34*	NULL
and	NULL
in	NULL
32Dc13	NULL
Cells	NULL
.	NULL

RNA	NULL
was	NULL
extracted	NULL
from	NULL
cultured	NULL
CD34*	NULL
and	NULL
32Dc13	NULL
cells	NULL
as	NULL
described	NULL
(	NULL
7	NULL
,	NULL
12	NULL
)	NULL
.	NULL

After	NULL
first-strand	NULL
cDNA	NULL
synthesis	NULL
using	NULL
10-30	NULL
ng	NULL
of	NULL
extracted	NULL
RNA	NULL
,	NULL
DR-nm23	NULL
mRNA	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
PCR	NULL
(	NULL
25	NULL
cycles	NULL
;	NULL
5	NULL
'	NULL
primer	NULL
,	NULL
5-GCACCTTCCTGGCCGTGAAG-3	NULL
'	NULL
;	NULL
3	NULL
'	NULL
primer	NULL
,	NULL
5'-AGG-TGCGCACCACGTCCAG-3	NULL
'	NULL
)	NULL
and	NULL
detected	NULL
by	NULL
Southern	NULL
hybridization	NULL
with	NULL
a	NULL
[	NULL
y-	NULL
>	NULL
°P	NULL
]	NULL
JATP	NULL
end-labeled	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
5-TAGTGCTCACGCAGCAGCT-3	NULL
'	NULL
)	NULL
specific	NULL
for	NULL
the	NULL
amplified	NULL
sequence	NULL
.	NULL

Myeloperoxidase	NULL
mRNA	NULL
expression	NULL
was	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
analyzed	NULL
by	NULL
PCR	NULL
(	NULL
25	NULL
cycles	NULL
)	NULL
with	NULL
specific	NULL
primers	NULL
(	NULL
forward	NULL
primer	NULL
,	NULL
reverse	NULL
primer	NULL
,	NULL
5-GTGTCCAGTGATGGTGCGATACTT	NULL
)	NULL
and	NULL
detected	NULL
by	NULL
Southern	NULL
blot	NULL
hybridization	NULL
with	NULL
the	NULL
primer	NULL
5'-TGCTCAGCTGAATCTGTTGTCCGT	NULL
.	NULL

Transfection	NULL
of	NULL
32Dc13	NULL
Cells	NULL
.	NULL

32Dc13	NULL
cells	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
resuspended	NULL
in	NULL
0.5	NULL
mi	NULL
of	NULL
phosphate-buffered	NULL
saline	NULL
and	NULL
elec-troporated	NULL
(	NULL
Gene	NULL
Pulser	NULL
;	NULL
Bio-Rad	NULL
;	NULL
340	NULL
V	NULL
/250	NULL
uF	NULL
)	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
resuspended	NULL
in	NULL
12.5	NULL
ml	NULL
of	NULL
IMDM	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
heat-inactivated	NULL
FBS	NULL
,	NULL
15	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
WEHI	NULL
conditioned	NULL
medium	NULL
,	NULL
and	NULL
200	NULL
ug	NULL
of	NULL
L-glutamine	NULL
per	NULL
ml	NULL
.	NULL

Cells	NULL
were	NULL
replated	NULL
48	NULL
h	NULL
later	NULL
in	NULL
selective	NULL
medium	NULL
containing	NULL
1	NULL
mg	NULL
of	NULL
G418	NULL
per	NULL
ml	NULL
.	NULL

After	NULL
a	NULL
2-week	NULL
selection	NULL
,	NULL
mixed	NULL
cell	NULL
populations	NULL
from	NULL
different	NULL
trans-fections	NULL
were	NULL
expanded	NULL
for	NULL
further	NULL
analysis	NULL
.	NULL

Detection	NULL
of	NULL
Apoptosis	NULL
by	NULL
DNA	NULL
Gel	NULL
Electrophoresis	NULL
.	NULL

Cells	NULL
treated	NULL
with	NULL
G-CSF	NULL
for	NULL
72	NULL
h	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
fixed	NULL
in	NULL
70	NULL
%	NULL
ethanol	NULL
.	NULL

DNA	NULL
extraction	NULL
and	NULL
gel	NULL
electrophoresis	NULL
for	NULL
detection	NULL
of	NULL
fragmented	NULL
DNA	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Western	NULL
Blotting	NULL
.	NULL

Equal	NULL
numbers	NULL
of	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
ice-cold	NULL
PBS	NULL
prior	NULL
to	NULL
lysis	NULL
with	NULL
1	NULL
ml	NULL
of	NULL
lysis	NULL
buffer	NULL
[	NULL
10	NULL
mM	NULL
Hepes	NULL
,	NULL
pH	NULL
7.5/150	NULL
mM	NULL
NaCIl/0.5	NULL
%	NULL
Nonidet	NULL
P-40/	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
glycerol/10	NULL
ug	NULL
of	NULL
leupeptin	NULL
and	NULL
25	NULL
ug	NULL
of	NULL
aprotinin	NULL
per	NULL
ml/1	NULL
mM	NULL
phenylmethylsulfonylfluoride/1	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

Lysate	NULL
preparation	NULL
,	NULL
SDS/PAGE	NULL
,	NULL
transfer	NULL
to	NULL
nitrocel-lulose	NULL
membranes	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
)	NULL
,	NULL
membrane	NULL
block-ing	NULL
,	NULL
and	NULL
incubation	NULL
with	NULL
primary	NULL
antibody	NULL
were	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
(	NULL
6	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
2	NULL
h	NULL
with	NULL
sheep	NULL
anti-mouse	NULL
IgG	NULL
conjugated	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
(	NULL
Am-ersham	NULL
)	NULL
,	NULL
bound	NULL
proteins	NULL
were	NULL
detected	NULL
by	NULL
using	NULL
chemilumi-nescent	NULL
substrates	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

RESULTS	NULL
Cloning	NULL
of	NULL
the	NULL
Full-Length	NULL
DR-nm23	NULL
cDNA	NULL
.	NULL

Differential	NULL
screening	NULL
of	NULL
a	NULL
CML-BC	NULL
cDNA	NULL
library	NULL
by	NULL
using	NULL
a	NULL
P-labeled	NULL
cDNA	NULL
prepared	NULL
from	NULL
RNA	NULL
of	NULL
the	NULL
lymphoblastic	NULL
leukemia	NULL
egetcecgcacegecatcBIGATCTGCCTGGTGCTGACCATCTTCGCTAACCTCTTCCCC	NULL
60	NULL
GCGGCCTGCACCGGCGCACACGAACGCACCTTCCTGGCCGTGAAGCCGGACGGCGTGCAG	NULL
120	NULL
CGGCGGCTGGTGGGCGAGATTGTGCGGCGCTTCGAGAGGAAGGGCTTCAAGTTGGTGGCG	NULL
180	NULL
CTGAAGCTGGTGCAGTCCTCCGAGGAGCTGCTGCGTGAGCACTACGCCGAGCTGCGTGAA	NULL
240	NULL
CGCCCGTTCTACGGCCGCCTTGTCAAGTATATGGCCTCCGGGCCGGTGGTGGCCATGGTT	NULL
300	NULL
TGGCAGGGGCTGGACGTGGTGCGCACCTCGCGEGCGCTCATCGGAGCCACGAACCCGGCC	NULL
360	NULL
GACGCCCCGCCCGGCACCATCCGCGGGGATTTCTGCATCGAGGTTGGCAACCTGATTCAC	NULL
420	NULL
GGCAGCGACTCGGTGGAGAGTGCCCGCCGCGAGATCGCTCTCTGGTTCCGCGCAGACGAG	NULL
480	NULL
CTCCTCTGCTGGGAGGACAGCGCTGGGCACTGGCTGTATGAGTAGecoggcagatgegey	NULL
540	NULL
tcacagaggctctcacattccagectcctccagqqcccagqtgqqgeqqcttctggcccca	NULL
600	NULL
coccacagegcttggagcatcoctttggacgqqgctgctgaacatccacctgtctggacgt	NULL
660	NULL
tgcatggaggqgtqqgegcagectctccaatcoctggegtacagqggtttectqgceccgaggac	NULL
720	NULL
780	NULL
agcccaacgtggtccaaggtttttttataattaaagtcctogttttcgttaaamaamaama	NULL
840	NULL
aaaaaaaaa	NULL
849	NULL
FiG	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Nucleotide	NULL
sequence	NULL
of	NULL
full-length	NULL
DR-nm23	NULL
cDNA	NULL
.	NULL

Translation	NULL
initiation	NULL
and	NULL
termination	NULL
codons	NULL
and	NULL
polyadenylylation	NULL
signal	NULL
are	NULL
underlined	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Venturelli	NULL
et	NULL
al	NULL
.	NULL

DR-nm23	NULL
Human	NULL
nm23	NULL
H1	NULL
Mouse	NULL
nm23	NULL
H1	NULL
Human	NULL
nm23	NULL
H2	NULL
Mouse	NULL
nm23	NULL
H2	NULL
Consensus	NULL
DR-nm23	NULL
Human	NULL
nm23	NULL
HI	NULL
Mouse	NULL
nm23	NULL
HI	NULL
Human	NULL
nm23	NULL
H2	NULL
Mouse	NULL
nm23	NULL
H2	NULL
Consensus	NULL
R	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
7437	NULL
100	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Amino	NULL
acid	NULL
sequence	NULL
comparison	NULL
among	NULL
human	NULL
and	NULL
DR-nm23	NULL
v	NULL
tlojv	NULL
Caf	NULL
?	NULL

®	NULL
P	NULL
A	NULL
dla_ef®	NULL
o	NULL
fT	NULL
K	NULL
Gb	NULL
F	NULL
C	NULL
flefy	NULL
n	NULL
G	NULL
5	NULL
b	NULL
5	NULL
v8	NULL
i142	NULL
-	NULL
mouse	NULL
DR-nm23	NULL
and	NULL
nm23-H1	NULL
Mouse	NULL
mats	NULL
mio	NULL
|V	NULL
wk	NULL
GLN	NULL
VV	NULL
R	NULL
Ta	NULL
RV	NULL
R	NULL
Lok	NULL
L	NULL
Ws	NULL
A	NULL
b	NULL
§	NULL
kb	NULL
64	NULL
PR	NULL
ab	NULL
bol	NULL
35313552333	NULL
?	NULL

1	NULL
,	NULL
-	NULL
and	NULL
nm23-H2	NULL
.	NULL

Sequence	NULL
compari-Hime	NULL
mebde	NULL
10	NULL
-	NULL
son	NULL
was	NULL
made	NULL
by	NULL
using	NULL
the	NULL
Swiss	NULL
Prot	NULL
data	NULL
base	NULL
from	NULL
the	NULL
Genetics	NULL
Consensus	NULL
v	NULL
vie	NULL
15°	NULL
_	NULL
Computer	NULL
Group	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
Sequence	NULL
Analysis	NULL
Software	NULL
Pack-DR-am23	NULL
R	NULL
RE	NULL
W	NULL
FIR	NULL
AJB	NULL
E	NULL
flu	NULL
s	NULL
b	NULL
s	NULL
[	NULL
Ale	NULL
E	NULL
ee	NULL
-	NULL
``	NULL
8¢	NULL
:	NULL
The	NULL
consensus	NULL
sequence	NULL
Top-Homan	NULL
nm23	NULL
HI	NULL
clu	NULL
w	NULL
rlafFoe	NULL
®	NULL
L	NULL
v	NULL
b	NULL
u	NULL
}	NULL
t	NULL
g	NULL
Tov	NULL
E	NULL
is	NULL
?	NULL

-	NULL
resents	NULL
residues	NULL
present	NULL
in	NULL
at	NULL
least	NULL
Moe	NULL
mey	NULL
(	NULL
1	NULL
,	NULL
23	NULL
?	NULL

”	NULL
16	NULL
Fhree	NULL
members	NULL
of	NULL
nth	NULL
;	NULL
nr_n-21	NULL
}	NULL
fam-Mouse	NULL
nm23	NULL
H2	NULL
s	NULL
[	NULL
z	NULL
w	NULL
rJolp	NULL
E	NULL
8	NULL
1	NULL
v	NULL
E	NULL
v	NULL
}	NULL
®	NULL
o	NULL
w	NULL
[	NULL
@	NULL
1	NULL
v	NULL
E	NULL
is2	NULL
_	NULL
ily	NULL
.	NULL

The	NULL
RGD	NULL
motif	NULL
is	NULL
highlighted	NULL
Consensus	NULL
RKB	NULL
I-	NULL
LW	NULL
P-	NULL
PBE	NULL
L	NULL
V-	NULL
Y-	NULL
8	NULL
CA	NULL
~-	NULL
W	NULL
IYE	NULL
114	NULL
_	NULL
in	NULL
boldface	NULL
type	NULL
.	NULL

T-cell	NULL
line	NULL
CCRF-CEM	NULL
as	NULL
the	NULL
probe	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
several	NULL
clones	NULL
preferentially	NULL
expressed	NULL
in	NULL
CML-BC	NULL
cells	NULL
.	NULL

Sequence	NULL
analysis	NULL
of	NULL
one	NULL
such	NULL
clone	NULL
revealed	NULL
an	NULL
approximately	NULL
70	NULL
%	NULL
sequence	NULL
similarity	NULL
to	NULL
the	NULL
mRNA	NULL
sequence	NULL
of	NULL
the	NULL
nm23-H1	NULL
and	NULL
nm23-H2	NULL
genes	NULL
,	NULL
postulated	NULL
to	NULL
act	NULL
as	NULL
metastatic	NULL
suppressor	NULL
genes	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

This	NULL
clone	NULL
was	NULL
named	NULL
DR-n	NULL
»	NULL
m23	NULL
.	NULL

The	NULL
originally	NULL
identified	NULL
clone	NULL
was	NULL
only	NULL
652	NULL
bp	NULL
long	NULL
,	NULL
did	NULL
not	NULL
contain	NULL
an	NULL
ATG	NULL
initiation	NULL
codon	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
canonical	NULL
consensus	NULL
sequence	NULL
for	NULL
translation	NULL
initiation	NULL
(	NULL
16	NULL
)	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
0.8-	NULL
to	NULL
1.0-kb	NULL
mRNA	NULL
species	NULL
.	NULL

Thus	NULL
,	NULL
primer	NULL
extension	NULL
analysis	NULL
performed	NULL
on	NULL
RNA	NULL
derived	NULL
from	NULL
CML-BC	NULL
and	NULL
CCRF-CEM	NULL
cells	NULL
revealed	NULL
two	NULL
extension	NULL
products	NULL
in	NULL
the	NULL
RNA	NULL
of	NULL
expressor	NULL
cells	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
existence	NULL
of	NULL
two	NULL
mRNA	NULL
transcripts	NULL
of	NULL
0.8-1.0	NULL
kb	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
full-length	NULL
DR-nm23	NULL
cDNA	NULL
,	NULL
obtained	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
is	NULL
849	NULL
bp	NULL
long	NULL
and	NULL
contains	NULL
an	NULL
open	NULL
reading	NULL
frame	NULL
for	NULL
a	NULL
predicted	NULL
protein	NULL
of	NULL
168	NULL
amino	NULL
acids	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
around	NULL
the	NULL
first	NULL
ATG	NULL
was	NULL
CCATCATGT	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
consensus	NULL
sequence	NULL
[	NULL
CC	NULL
(	NULL
A/G	NULL
)	NULL
CCATGG	NULL
]	NULL
for	NULL
eukaryotic	NULL
mRNA	NULL
translation	NULL
initiation	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
translation	NULL
of	NULL
DRnm23	NULL
into	NULL
the	NULL
transcription/translation	NULL
vector	NULL
pcDNA3	NULL
generated	NULL
a	NULL
protein	NULL
of	NULL
approximately	NULL
18,000	NULL
Da	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Amino	NULL
Acid	NULL
Sequence	NULL
Comparison	NULL
Among	NULL
DR-nm23	NULL
,	NULL
nm23-H1	NULL
,	NULL
and	NULL
nm23-H2	NULL
.	NULL

The	NULL
DR-nm23	NULL
protein	NULL
has	NULL
66.9	NULL
%	NULL
and	NULL
64.9	NULL
%	NULL
amino	NULL
acid	NULL
sequence	NULL
identity	NULL
,	NULL
respectively	NULL
,	NULL
to	NULL
the	NULL
human	NULL
nm23-H1	NULL
and	NULL
nm23-H2	NULL
proteins	NULL
.	NULL

The	NULL
nm23-H1	NULL
and	NULL
Myeloid	NULL
DR-om23	NULL
«	NULL
@	NULL
@	NULL
tt	NULL
a	NULL
Undifferentiated	NULL
<	NULL
-	NULL
262	NULL
bp	NULL
B	NULL
;	NULL
-microglobulin	NULL
«	NULL
saat	NULL
<	NULL
-	NULL
209	NULL
bp	NULL
0	NULL
3	NULL
5	NULL
7	NULL
9	NULL
12	NULL
14	NULL
16	NULL
days	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Kinetics	NULL
of	NULL
DR-nm23	NULL
mRNA	NULL
expression	NULL
during	NULL
myeloid	NULL
differentiation	NULL
of	NULL
human	NULL
CD34+*	NULL
progenitor	NULL
cells	NULL
.	NULL

Reverse	NULL
transcription-PCR	NULL
was	NULL
performed	NULL
before	NULL
(	NULL
day	NULL
0	NULL
)	NULL
and	NULL
after	NULL
the	NULL
indicated	NULL
times	NULL
in	NULL
culture	NULL
with	NULL
IL-3	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
,	NULL
and	NULL
G-CSF	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

Specificity	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
was	NULL
confirmed	NULL
by	NULL
Southern	NULL
blot	NULL
analysis	NULL
using	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
included	NULL
with	NULL
the	NULL
amplified	NULL
fragment	NULL
.	NULL

B	NULL
;	NULL
»	NULL
Microglobulin	NULL
levels	NULL
were	NULL
measured	NULL
as	NULL
control	NULL
.	NULL

Each	NULL
lane	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

nm23-H2	NULL
proteins	NULL
have	NULL
a	NULL
putative	NULL
leucine-zipper	NULL
domain	NULL
(	NULL
17	NULL
)	NULL
.	NULL

A	NULL
similar	NULL
leucine	NULL
zipper-like	NULL
structure	NULL
present	NULL
in	NULL
the	NULL
DR-nm23	NULL
protein	NULL
spans	NULL
from	NULL
amino	NULL
acid	NULL
60	NULL
to	NULL
84	NULL
and	NULL
shares	NULL
54	NULL
%	NULL
and	NULL
45.8	NULL
%	NULL
sequence	NULL
identity	NULL
with	NULL
the	NULL
nm23-H1	NULL
and	NULL
nm23-H2	NULL
proteins	NULL
,	NULL
respectively	NULL
.	NULL

An	NULL
RGD	NULL
motif	NULL
,	NULL
implicated	NULL
in	NULL
cell	NULL
attachment	NULL
to	NULL
fibronectin	NULL
and	NULL
other	NULL
proteins	NULL
involved	NULL
in	NULL
cell	NULL
adhesion	NULL
(	NULL
18	NULL
)	NULL
,	NULL
is	NULL
conserved	NULL
in	NULL
the	NULL
nm23	NULL
proteins	NULL
;	NULL
such	NULL
a	NULL
motif	NULL
and	NULL
the	NULL
surrounding	NULL
amino	NULL
acids	NULL
are	NULL
also	NULL
maintained	NULL
in	NULL
the	NULL
DR-nm23	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
in	NULL
boldface	NULL
type	NULL
)	NULL
.	NULL

A	NULL
serine	NULL
residue	NULL
at	NULL
position	NULL
44	NULL
in	NULL
the	NULL
nm23	NULL
protein	NULL
,	NULL
a	NULL
major	NULL
phosphorylation	NULL
site	NULL
found	NULL
to	NULL
correlate	NULL
with	NULL
suppression	NULL
of	NULL
cell	NULL
metastatic	NULL
potential	NULL
(	NULL
19	NULL
)	NULL
,	NULL
and	NULL
a	NULL
histidine	NULL
residue	NULL
at	NULL
position	NULL
118	NULL
of	NULL
the	NULL
nm23	NULL
protein	NULL
that	NULL
is	NULL
critical	NULL
for	NULL
its	NULL
nucleoside-diphosphate	NULL
kinase	NULL
activity	NULL
(	NULL
19	NULL
)	NULL
are	NULL
present	NULL
in	NULL
the	NULL
predicted	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
DR-nm23	NULL
at	NULL
residues	NULL
61	NULL
and	NULL
134	NULL
,	NULL
respectively	NULL
.	NULL

DR-nm23	NULL
Expression	NULL
During	NULL
Myeloid	NULL
Differentiation	NULL
in	NULL
Vitro	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
pattern	NULL
of	NULL
DR-nm23	NULL
expression	NULL
during	NULL
hematopoietic	NULL
differentiation	NULL
,	NULL
human	NULL
peripheral	NULL
blood	NULL
CD34*	NULL
cells	NULL
obtained	NULL
from	NULL
healthy	NULL
donors	NULL
were	NULL
induced	NULL
to	NULL
differentiate	NULL
toward	NULL
the	NULL
myeloid	NULL
pathway	NULL
.	NULL

At	NULL
day	NULL
0	NULL
and	NULL
after	NULL
3	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
14	NULL
,	NULL
and	NULL
16	NULL
days	NULL
of	NULL
in	NULL
vitro	NULL
differentiation	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
assessed	NULL
for	NULL
DR-nm23	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

DR-nm23	NULL
mRNA	NULL
was	NULL
detectable	NULL
in	NULL
undifferentiated	NULL
CD34*	NULL
cells	NULL
and	NULL
readily	NULL
increased	NULL
on	NULL
day	NULL
3	NULL
of	NULL
differentiation	NULL
;	NULL
such	NULL
levels	NULL
declined	NULL
thereafter	NULL
and	NULL
were	NULL
barely	NULL
detectable	NULL
by	NULL
day	NULL
12.	NULL
on	NULL
e	NULL
is	NULL
[	NULL
s	NULL
]	NULL
-	NULL
A	NULL
E	NULL
o	NULL
o	NULL
SEW	NULL
E	NULL
5	NULL
B	NULL
Io	NULL
f	NULL
&	NULL
a	NULL
z	NULL
-	NULL
a	NULL
a	NULL
é	NULL
2	NULL
40	NULL
b	NULL
&	NULL
;	NULL
g	NULL
6	NULL
.	NULL

-	NULL
£0	NULL
%	NULL
)	NULL
%	NULL
h	NULL
=	NULL
_	NULL
__	NULL
.	NULL

a	NULL
a	NULL
43	NULL
kDa	NULL
-m	NULL
28S	NULL
29	NULL
kDa	NULL
188	NULL
B-actin	NULL
[	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

DRnm23	NULL
expression	NULL
in	NULL
transfected	NULL
32Dc13	NULL
cells	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
DR-nm23	NULL
mRNA	NULL
levels	NULL
in	NULL
parental	NULL
,	NULL
pLXSN-transfected	NULL
,	NULL
and	NULL
DR-nm23-transfected	NULL
32Dc13	NULL
cells	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
HA-tagged	NULL
DR-nm23	NULL
protein	NULL
in	NULL
transfected	NULL
32Dc13	NULL
cells	NULL
detected	NULL
with	NULL
the	NULL
12CAS	NULL
anti-HA	NULL
epitope	NULL
monoclonal	NULL
antibody	NULL
.	NULL

7438	NULL
Medical	NULL
Sciences	NULL
:	NULL
Venturelli	NULL
et	NULL
al	NULL
.	NULL

LXSN	NULL
This	NULL
pattern	NULL
of	NULL
expression	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
function	NULL
for	NULL
DR-nm23	NULL
during	NULL
early	NULL
stages	NULL
of	NULL
hematopoiesis	NULL
.	NULL

Expression	NULL
of	NULL
DR-nm23	NULL
in	NULL
32Dc13	NULL
Cells	NULL
Blocks	NULL
G-CSF-Induced	NULL
Granulocytic	NULL
Differentiation	NULL
and	NULL
Causes	NULL
Apoptosis	NULL
.	NULL

32Dc13	NULL
cells	NULL
were	NULL
derived	NULL
from	NULL
normal	NULL
mouse	NULL
bone	NULL
marrow	NULL
progenitors	NULL
and	NULL
undergo	NULL
terminal	NULL
myeloid	NULL
differentiation	NULL
when	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
G-CSF	NULL
(	NULL
19	NULL
)	NULL
.	NULL

32Dc13	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
pLXSN	NULL
parental	NULL
vector	NULL
or	NULL
with	NULL
pLXSN-DR-nm23	NULL
,	NULL
linked	NULL
or	NULL
unlinked	NULL
to	NULL
an	NULL
in-frame	NULL
HA	NULL
epitope	NULL
,	NULL
allowed	NULL
to	NULL
proliferate	NULL
,	NULL
and	NULL
assessed	NULL
for	NULL
DR-nm23	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
with	NULL
a	NULL
*°P-labeled	NULL
DR-nm23	NULL
cDNA	NULL
insert	NULL
revealed	NULL
the	NULL
expected	NULL
transcripts	NULL
of	NULL
the	NULL
DR-nm23-containing	NULL
retrovirus	NULL
vector	NULL
in	NULL
transfected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

Endogenous	NULL
DR-nm23	NULL
transcripts	NULL
were	NULL
barely	NULL
detectable	NULL
only	NULL
after	NULL
a	NULL
5-day	NULL
exposure	NULL
of	NULL
the	NULL
blot	NULL
,	NULL
perhaps	NULL
reflecting	NULL
low	NULL
levels	NULL
of	NULL
expression	NULL
in	NULL
parental	NULL
cells	NULL
and/or	NULL
sequence	NULL
heterogeneity	NULL
between	NULL
mouse	NULL
and	NULL
human	NULL
mRNAs	NULL
.	NULL

Use	NULL
of	NULL
anti-HA	NULL
monoclonal	NULL
antibody	NULL
12CAS	NULL
allowed	NULL
LXSN	NULL
#	NULL
«	NULL
:	NULL
o	NULL
@	NULL
@	NULL
C	NULL
@	NULL
C	NULL
@	NULL
@	NULL
eccctcb	NULL
0	NULL
24	NULL
48	NULL
72	NULL
84	NULL
96	NULL
LXSN-DR-nm23	NULL
MPO	NULL
0	NULL
24	NULL
48	NULL
72	NULL
84	NULL
96	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Myeloperoxidase	NULL
(	NULL
MPO	NULL
)	NULL
mRNA	NULL
levels	NULL
in	NULL
parental	NULL
LXSN-and	NULL
DR-nm23-transfected	NULL
32Dc13	NULL
cells	NULL
cultured	NULL
in	NULL
G-CSF	NULL
containing	NULL
medium	NULL
.	NULL

Reverse	NULL
transcription-PCR	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
on	NULL
pLXSN-	NULL
and	NULL
DR-nm23-transfected	NULL
32Dc13	NULL
cells	NULL
.	NULL

Endogenous	NULL
B-actin	NULL
mRNA	NULL
levels	NULL
were	NULL
also	NULL
measured	NULL
as	NULL
a	NULL
control	NULL
for	NULL
RNA	NULL
amounts	NULL
.	NULL

Time	NULL
in	NULL
culture	NULL
(	NULL
in	NULL
h	NULL
)	NULL
is	NULL
indicated	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

Each	NULL
lane	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

®	NULL
og	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
3	NULL
§	NULL
FiG	NULL
.	NULL

5	NULL
.	NULL

Morphology	NULL
of	NULL
pLXSN-and	NULL
DR-nm23-transfected	NULL
32Dc13	NULL
cells	NULL
cultured	NULL
in	NULL
G-CSF-containing	NULL
``	NULL
at	NULL
C	NULL
G	NULL
x	NULL
al	NULL
medium	NULL
.	NULL

Cells	NULL
,	NULL
cultured	NULL
in	NULL
G-CSF-¢	NULL
¥ﬂw	NULL
f	NULL
.	NULL

&	NULL
Ro	NULL
«	NULL
-	NULL
containing	NULL
medium	NULL
for	NULL
0	NULL
,	NULL
3	NULL
,	NULL
or	NULL
9	NULL
_	NULL
%	NULL
[	NULL
¥	NULL
*	NULL
%	NULL
days	NULL
,	NULL
were	NULL
cytocentrifuged	NULL
onto	NULL
-_	NULL
#	NULL
a	NULL
)	NULL
>	NULL
v	NULL
slides	NULL
.	NULL

Slides	NULL
were	NULL
air	NULL
dried	NULL
and	NULL
.	NULL

*	NULL
o	NULL
#	NULL
*	NULL
f	NULL
©	NULL
stained	NULL
with	NULL
Giemsa	NULL
.	NULL

The	NULL
arrow	NULL
indicates	NULL
one	NULL
of	NULL
the	NULL
numerous	NULL
apoptotic	NULL
bodies	NULL
visible	NULL
after	NULL
3	NULL
days	NULL
of	NULL
culture	NULL
.	NULL

By	NULL
day	NULL
9	NULL
,	NULL
the	NULL
large	NULL
majority	NULL
of	NULL
DR-nm23-transfected	NULL
cells	NULL
had	NULL
g	NULL
become	NULL
ghost-like	NULL
.	NULL

detection	NULL
of	NULL
a	NULL
protein	NULL
with	NULL
the	NULL
expected	NULL
size	NULL
for	NULL
DR-nm23	NULL
and	NULL
the	NULL
in-frame	NULL
triple	NULL
HA	NULL
epitope	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Parental	NULL
and	NULL
pLXSN-transfected	NULL
32Dc13	NULL
cells	NULL
,	NULL
when	NULL
cultured	NULL
with	NULL
G-CSF	NULL
,	NULL
retained	NULL
viability	NULL
during	NULL
the	NULL
initial	NULL
days	NULL
of	NULL
incubation	NULL
in	NULL
differentiation	NULL
medium	NULL
;	NULL
like	NULL
parental	NULL
cells	NULL
,	NULL
pLXSN-transfected	NULL
32Dc13	NULL
cells	NULL
underwent	NULL
terminal	NULL
differentiation	NULL
to	NULL
morphologically	NULL
recognizable	NULL
granulocytes	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
DR-nm23-transfected	NULL
32D¢c13	NULL
cells	NULL
lost	NULL
viability	NULL
at	NULL
early	NULL
times	NULL
in	NULL
differentiation	NULL
medium	NULL
and	NULL
failed	NULL
to	NULL
terminally	NULL
differentiate	NULL
upon	NULL
treatment	NULL
with	NULL
G-CSF	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Myeloperoxidase	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
G-CSF-treated	NULL
32Dc13	NULL
cells	NULL
transfected	NULL
with	NULL
pLXSN	NULL
after	NULL
3-4	NULL
days	NULL
of	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
these	NULL
transcripts	NULL
were	NULL
undetectable	NULL
in	NULL
DR-nm23-transfected	NULL
32Dc13	NULL
cells	NULL
for	NULL
up	NULL
to	NULL
4	NULL
days	NULL
of	NULL
G-CSF	NULL
treatment	NULL
,	NULL
after	NULL
which	NULL
time	NULL
no	NULL
viable	NULL
cells	NULL
were	NULL
recovered	NULL
for	NULL
RNA	NULL
extraction	NULL
.	NULL

DR-nm23-transfected	NULL
cells	NULL
appeared	NULL
to	NULL
die	NULL
of	NULL
apoptosis	NULL
,	NULL
as	NULL
revealed	NULL
by	NULL
morphology	NULL
and	NULL
1375	NULL
831	NULL
504	NULL
267	NULL
FiG	NULL
.	NULL

7	NULL
.	NULL

-	NULL
DNA	NULL
gel	NULL
electrophoresis	NULL
of	NULL
nontransfected	NULL
and	NULL
LXSN-	NULL
and	NULL
DR-nm23-transfected	NULL
32Dc13	NULL
cells	NULL
after	NULL
a	NULL
72-h	NULL
exposure	NULL
to	NULL
G-CSF	NULL
.	NULL

DNA	NULL
was	NULL
analyzed	NULL
by	NULL
gel	NULL
electrophoresis	NULL
as	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
molecular	NULL
weight	NULL
markers	NULL
;	NULL
lane	NULL
3	NULL
,	NULL
DR-nm23-transfected	NULL
32Dc13	NULL
cells	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
pLXSN-transfected	NULL
32Dc13	NULL
cells	NULL
;	NULL
and	NULL
lane	NULL
5	NULL
,	NULL
parental	NULL
32Dc13	NULL
cells	NULL
.	NULL

Left	NULL
,	NULL
size	NULL
markers	NULL
in	NULL
bp	NULL
.	NULL

Medical	NULL
Sciences	NULL
:	NULL
Venturelli	NULL
et	NULL
al	NULL
.	NULL

DNA	NULL
gel	NULL
electrophoresis	NULL
evidence	NULL
of	NULL
a	NULL
typical	NULL
DNA	NULL
fragmentation	NULL
pattern	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

DISCUSSION	NULL
By	NULL
differential	NULL
screening	NULL
of	NULL
a	NULL
CML-BC	NULL
cDNA	NULL
library	NULL
,	NULL
we	NULL
have	NULL
isolated	NULL
a	NULL
gene	NULL
with	NULL
sequence	NULL
homology	NULL
to	NULL
nm23-H1I	NULL
and	NULL
nm23-H2	NULL
,	NULL
originally	NULL
identified	NULL
as	NULL
putative	NULL
metastatic	NULL
suppressor	NULL
genes	NULL
.	NULL

The	NULL
encoded	NULL
protein	NULL
has	NULL
~65	NULL
%	NULL
amino	NULL
acid	NULL
similarity	NULL
to	NULL
nm23-H1	NULL
and	NULL
nm23-H2	NULL
.	NULL

A	NULL
putative	NULL
leucine-zipper	NULL
domain	NULL
and	NULL
the	NULL
RGD	NULL
domain	NULL
implicated	NULL
in	NULL
integrin	NULL
recognition	NULL
in	NULL
proteins	NULL
involved	NULL
in	NULL
cell	NULL
attachment	NULL
(	NULL
18	NULL
)	NULL
are	NULL
conserved	NULL
among	NULL
the	NULL
different	NULL
proteins	NULL
.	NULL

Their	NULL
relevance	NULL
for	NULL
nm23	NULL
function	NULL
is	NULL
unknown	NULL
,	NULL
in	NULL
part	NULL
because	NULL
the	NULL
precise	NULL
role	NULL
of	NULL
nm23	NULL
in	NULL
normal	NULL
processes	NULL
,	NULL
such	NULL
as	NULL
proliferation	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
neoplastic	NULL
transformation	NULL
,	NULL
is	NULL
still	NULL
controversial	NULL
.	NULL

It	NULL
was	NULL
originally	NULL
reported	NULL
that	NULL
nm23	NULL
mRNA	NULL
levels	NULL
were	NULL
uniformly	NULL
reduced	NULL
in	NULL
rodent	NULL
cell	NULL
lines	NULL
with	NULL
high	NULL
metastatic	NULL
potential	NULL
and	NULL
in	NULL
lymph-node	NULL
metastases	NULL
of	NULL
human	NULL
infiltrating	NULL
ductal	NULL
breast	NULL
carcinomas	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Of	NULL
greater	NULL
importance	NULL
,	NULL
»	NULL
n	NULL
»	NULL
m23-transfected	NULL
,	NULL
highly	NULL
metastatic	NULL
melanoma	NULL
cells	NULL
exhibited	NULL
reduced	NULL
incidence	NULL
of	NULL
primary	NULL
tumor	NULL
formation	NULL
,	NULL
significant	NULL
reduction	NULL
in	NULL
tumor	NULL
metastatic	NULL
potential	NULL
,	NULL
and	NULL
altered	NULL
response	NULL
to	NULL
transforming	NULL
growth	NULL
factor	NULL
B1	NULL
compared	NULL
with	NULL
untransfected	NULL
parental	NULL
cells	NULL
(	NULL
15	NULL
)	NULL
.	NULL

However	NULL
,	NULL
metastatic	NULL
phenotype	NULL
and	NULL
nm23	NULL
expression	NULL
are	NULL
positively	NULL
correlated	NULL
in	NULL
pancreatic	NULL
,	NULL
prostatic	NULL
,	NULL
and	NULL
ovarian	NULL
carcinomas	NULL
(	NULL
21-23	NULL
)	NULL
and	NULL
in	NULL
neuroblastomas	NULL
(	NULL
24	NULL
)	NULL
,	NULL
thus	NULL
raising	NULL
the	NULL
possibility	NULL
that	NULL
nm23	NULL
exerts	NULL
distinct	NULL
functions	NULL
in	NULL
different	NULL
tissue	NULL
types	NULL
.	NULL

nm23	NULL
levels	NULL
correlated	NULL
with	NULL
proliferation	NULL
in	NULL
mitogen-stimulated	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
and	NULL
decreased	NULL
during	NULL
terminal	NULL
differentiation	NULL
of	NULL
HL-60	NULL
cells	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
these	NULL
observations	NULL
,	NULL
a	NULL
differentiation-in-hibiting	NULL
factor	NULL
for	NULL
mouse	NULL
myeloid	NULL
leukemic	NULL
M1	NULL
cells	NULL
was	NULL
identified	NULL
as	NULL
the	NULL
nm23	NULL
protein	NULL
(	NULL
26	NULL
)	NULL
and	NULL
constitutive	NULL
expression	NULL
of	NULL
a	NULL
full-length	NULL
n	NULL
»	NULL
m23	NULL
cDNA	NULL
inhibited	NULL
differentiation	NULL
of	NULL
MEG-01	NULL
,	NULL
but	NULL
not	NULL
K562	NULL
,	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
DR-nm23	NULL
mRNA	NULL
expression	NULL
during	NULL
myeloid	NULL
differentiation	NULL
of	NULL
CD34	NULL
*	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
supports	NULL
a	NULL
role	NULL
for	NULL
this	NULL
gene	NULL
during	NULL
early	NULL
stages	NULL
of	NULL
hematopoietic	NULL
differentiation	NULL
and	NULL
is	NULL
consistent	NULL
with	NULL
its	NULL
identification	NULL
by	NULL
differential	NULL
screening	NULL
of	NULL
a	NULL
CML-BC	NULL
cDNA	NULL
library	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
comparison	NULL
of	NULL
DR-nm23	NULL
levels	NULL
in	NULL
chronic	NULL
phase	NULL
and	NULL
blast	NULL
crisis	NULL
samples	NULL
consistently	NULL
revealed	NULL
higher	NULL
expression	NULL
levels	NULL
in	NULL
the	NULL
blast	NULL
crisis	NULL
group	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Of	NULL
greater	NULL
importance	NULL
,	NULL
constitutive	NULL
expression	NULL
of	NULL
DR-nm23	NULL
in	NULL
32Dc13	NULL
cells	NULL
prevented	NULL
G-CSF-induced	NULL
granulocyte	NULL
differentiation	NULL
and	NULL
caused	NULL
apoptosis	NULL
of	NULL
these	NULL
cells	NULL
(	NULL
Figs	NULL
.	NULL

5-7	NULL
)	NULL
.	NULL

The	NULL
phenotype	NULL
of	NULL
DR-nm23-transfected	NULL
32Dc13	NULL
cells	NULL
is	NULL
reminiscent	NULL
of	NULL
that	NULL
described	NULL
for	NULL
Evi-1-transfected	NULL
32D¢c13	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
transfected	NULL
cells	NULL
require	NULL
IL-3	NULL
for	NULL
their	NULL
growth	NULL
,	NULL
manifest	NULL
a	NULL
block	NULL
in	NULL
differentiation	NULL
upon	NULL
IL-3	NULL
removal	NULL
and	NULL
addition	NULL
of	NULL
G-CSF	NULL
,	NULL
and	NULL
rapidly	NULL
undergo	NULL
cell	NULL
death	NULL
.	NULL

This	NULL
phenotype	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
induced	NULL
by	NULL
constitutive	NULL
expression	NULL
of	NULL
v-ab/	NULL
or	NULL
which	NULL
,	NULL
instead	NULL
,	NULL
involves	NULL
both	NULL
IL-3	NULL
independence	NULL
and	NULL
the	NULL
inability	NULL
to	NULL
differentiate	NULL
in	NULL
response	NULL
to	NULL
G-CSF	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

As	NULL
differentiation	NULL
arrest	NULL
is	NULL
a	NULL
feature	NULL
of	NULL
CML-BC	NULL
,	NULL
the	NULL
phenotype	NULL
of	NULL
DR-nm23-transfected	NULL
32Dc13	NULL
cells	NULL
might	NULL
be	NULL
relevant	NULL
to	NULL
explain	NULL
the	NULL
alteration	NULL
of	NULL
the	NULL
hematopoietic	NULL
differentiation	NULL
program	NULL
typical	NULL
of	NULL
that	NULL
disease	NULL
stage	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
chronic	NULL
phase	NULL
,	NULL
CML	NULL
progenitor	NULL
cells	NULL
retain	NULL
the	NULL
ability	NULL
to	NULL
differentiate	NULL
,	NULL
despite	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
BCR-ABL	NULL
protein	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
limited	NULL
leukemogenic	NULL
potential	NULL
of	NULL
BCR-ABL	NULL
proteins	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Since	NULL
BCR-ABL	NULL
expression	NULL
prolongs	NULL
the	NULL
survival	NULL
of	NULL
CML	NULL
myeloid	NULL
cells	NULL
by	NULL
inhibiting	NULL
apoptosis	NULL
(	NULL
20	NULL
)	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
coexpression	NULL
of	NULL
BCR-ABL	NULL
and	NULL
of	NULL
a	NULL
gene	NULL
like	NULL
DR-nm23	NULL
generates	NULL
a	NULL
cell	NULL
phenotype	NULL
resembling	NULL
that	NULL
of	NULL
CML-BC	NULL
blast	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
7439	NULL
The	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
associated	NULL
with	NULL
the	NULL
differentiation	NULL
arrest	NULL
and	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
DR-nm23-transfected	NULL
32Dc13	NULL
cells	NULL
is	NULL
,	NULL
at	NULL
the	NULL
moment	NULL
,	NULL
unknown	NULL
.	NULL

Thus	NULL
far	NULL
,	NULL
we	NULL
could	NULL
not	NULL
find	NULL
evidence	NULL
of	NULL
changes	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
p53	NULL
,	NULL
bel2	NULL
,	NULL
and	NULL
c-myc	NULL
,	NULL
that	NULL
negatively	NULL
or	NULL
positively	NULL
regulate	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
effects	NULL
associated	NULL
with	NULL
mutation	NULL
of	NULL
the	NULL
putative	NULL
nm-23	NULL
functional	NULL
domains	NULL
is	NULL
expected	NULL
to	NULL
provide	NULL
relevant	NULL
information	NULL
on	NULL
the	NULL
pathway	NULL
involved	NULL
in	NULL
the	NULL
DR-nm23-induced	NULL
phenotype	NULL
.	NULL

This	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
American	NULL
Cancer	NULL
Society	NULL
and	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
to	NULL
B.C	NULL
.	NULL
)	NULL

.	NULL

C.C	NULL
.	NULL

,	NULL
P.M.	NULL
,	NULL
and	NULL
G.S	NULL
.	NULL

were	NULL
supported	NULL
by	NULL
a	NULL
fellowship	NULL
of	NULL
the	NULL
Associazione	NULL
Italiana	NULL
Ricerca	NULL
sul	NULL
Cancro	NULL
.	NULL

1	NULL
.	NULL

Trinchieri	NULL
,	NULL
G.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
in	NULL
Neoplastic	NULL
Hematopathology	NULL
,	NULL
ed	NULL
.	NULL

Knowles	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
William	NULL
&	NULL
Wilkins	NULL
,	NULL
Baltimore	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

1-25	NULL
.	NULL

2	NULL
.	NULL

Rowley	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1982	NULL
)	NULL
Science	NULL
216	NULL
,	NULL
749-751	NULL
.	NULL

3	NULL
.	NULL

Groffen	NULL
,	NULL
J.	NULL
,	NULL
Stephenson	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Heisterkamp	NULL
,	NULL
N.	NULL
,	NULL
de	NULL
Klein	NULL
,	NULL
A.	NULL
,	NULL
Bar-tram	NULL
,	NULL
C.	NULL
R.	NULL
&	NULL
Grosveld	NULL
,	NULL
G.	NULL
(	NULL
1984	NULL
)	NULL
Cell	NULL
36	NULL
,	NULL
93-99	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Kantarjian	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Deisseroth	NULL
,	NULL
A.	NULL
,	NULL
Kurzrock	NULL
,	NULL
R.	NULL
,	NULL
Estrov	NULL
,	NULL
Z	NULL
.	NULL

&	NULL
Talpaz	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Blood	NULL
82	NULL
,	NULL
691-703	NULL
.	NULL

Gubler	NULL
,	NULL
V.	NULL
&	NULL
Hoffman	NULL
,	NULL
B.	NULL
J	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Gene	NULL
25	NULL
,	NULL
263-269	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
&	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1984	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Lab	NULL
.	NULL

Press	NULL
,	NULL
Plainview	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

7	NULL
.	NULL

Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.J.	NULL
&	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
18	NULL
,	NULL
5294-5299	NULL
.	NULL

8	NULL
.	NULL

Feinberg	NULL
,	NULL
A.	NULL
P.	NULL
&	NULL
Vogelstein	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

132	NULL
,	NULL
6-13	NULL
.	NULL

9	NULL
.	NULL

Miller	NULL
,	NULL
A.	NULL
D.	NULL
&	NULL
Rosmall	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
BioTechniques	NULL
7	NULL
,	NULL
980-982	NULL
.	NULL

10	NULL
.	NULL

Ma	NULL
,	NULL
X.-P.	NULL
&	NULL
Calabretta	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

54	NULL
,	NULL
6512-6516	NULL
.	NULL

11	NULL
.	NULL

Greenberger	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Sakakeeny	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Humphries	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Eaves	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

&	NULL
Eckner	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
80	NULL
,	NULL
2931-2935	NULL
.	NULL

12	NULL
.	NULL

-	NULL
Sposi	NULL
,	NULL
N.	NULL
H.	NULL
,	NULL
Zon	NULL
,	NULL
G.	NULL
I.	NULL
,	NULL
Care	NULL
,	NULL
A.	NULL
,	NULL
Valtieri	NULL
,	NULL
M.	NULL
,	NULL
Testa	NULL
,	NULL
V.	NULL
,	NULL
Gabbianelli	NULL
,	NULL
M.	NULL
,	NULL
Moriani	NULL
,	NULL
G.	NULL
,	NULL
Bottero	NULL
,	NULL
L.	NULL
,	NULL
Mather	NULL
,	NULL
C.	NULL
,	NULL
Orkin	NULL
,	NULL
S.	NULL
H.	NULL
&	NULL
Peschle	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
6353-6357	NULL
.	NULL

13	NULL
.	NULL

Gong	NULL
,	NULL
J.	NULL
,	NULL
Traganos	NULL
,	NULL
F.	NULL
&	NULL
Darzynkiewiez	NULL
,	NULL
Z	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

218	NULL
,	NULL
314-319	NULL
.	NULL

14	NULL
.	NULL

Rosengard	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Krutzsch	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
Shearn	NULL
,	NULL
A.	NULL
,	NULL
Biggs	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Barker	NULL
,	NULL
E.	NULL
,	NULL
Margulies	NULL
,	NULL
I.	NULL
M.	NULL
K.	NULL
,	NULL
King	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Liotta	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

&	NULL
Steeg	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
342	NULL
,	NULL
177-180	NULL
.	NULL

15	NULL
.	NULL

Leone	NULL
,	NULL
A.	NULL
,	NULL
Flatow	NULL
,	NULL
U.	NULL
,	NULL
King	NULL
,	NULL
R.C	NULL
.	NULL

,	NULL
Saudeen	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Margulies	NULL
,	NULL
I.	NULL
M.	NULL
K.	NULL
,	NULL
Liotta	NULL
,	NULL
L.	NULL
A	NULL
.	NULL

&	NULL
Steeg	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Cell	NULL
65	NULL
,	NULL
25-35	NULL
.	NULL

16	NULL
.	NULL

Kozak	NULL
,	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

12	NULL
,	NULL
857-872	NULL
.	NULL

17	NULL
.	NULL

Stahl	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Leone	NULL
,	NULL
A.	NULL
,	NULL
Rosengard	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
Porter	NULL
,	NULL
L.	NULL
,	NULL
King	NULL
,	NULL
R.C	NULL
.	NULL

&	NULL
Steeg	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1991	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

51	NULL
,	NULL
445-449	NULL
.	NULL

18	NULL
.	NULL

Ruoslahti	NULL
,	NULL
E.	NULL
&	NULL
Pierschbacher	NULL
,	NULL
M.	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
238	NULL
,	NULL
491-497	NULL
.	NULL

19	NULL
.	NULL

MacDonald	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
De	NULL
La	NULL
Rosa	NULL
,	NULL
A.	NULL
,	NULL
Benedict	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Freije	NULL
,	NULL
J.	NULL
M.	NULL
P.	NULL
,	NULL
Krutsch	NULL
,	NULL
H.	NULL
&	NULL
Steeg	NULL
,	NULL
P.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
25780-25789	NULL
.	NULL

20	NULL
.	NULL

-	NULL
Bedi	NULL
,	NULL
A.	NULL
,	NULL
Zehanbauer	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Barber	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Sharkis	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

&	NULL
Jones	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Blood	NULL
83	NULL
,	NULL
2038-2044	NULL
.	NULL

21	NULL
.	NULL

Nakamori	NULL
,	NULL
S.	NULL
,	NULL
Ishikawa	NULL
,	NULL
O.	NULL
,	NULL
Ohhigashi	NULL
,	NULL
H.	NULL
,	NULL
Kameyama	NULL
,	NULL
M.	NULL
,	NULL
Furukawa	NULL
,	NULL
H.	NULL
,	NULL
Sasaku	NULL
,	NULL
Y.	NULL
,	NULL
Inaju	NULL
,	NULL
H.	NULL
,	NULL
Higashiyama	NULL
,	NULL
M.	NULL
,	NULL
Imaoka	NULL
,	NULL
S.	NULL
,	NULL
Iwanuga	NULL
,	NULL
T.	NULL
,	NULL
Funac	NULL
,	NULL
H.	NULL
,	NULL
Wade	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Kimura	NULL
,	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
Clin	NULL
.	NULL

Exp	NULL
.	NULL

Metastasis	NULL
11	NULL
,	NULL
151-158	NULL
.	NULL

22	NULL
.	NULL

Igawa	NULL
,	NULL
M.	NULL
,	NULL
Rukstalis	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
Tanabe	NULL
,	NULL
T.	NULL
&	NULL
Chodak	NULL
,	NULL
G.	NULL
W.	NULL
(	NULL
1994	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

54	NULL
,	NULL
1313-1318	NULL
.	NULL

23	NULL
.	NULL

Mandai	NULL
,	NULL
M.	NULL
,	NULL
Konishi	NULL
,	NULL
I.	NULL
,	NULL
Koshiyama	NULL
,	NULL
M.	NULL
,	NULL
Mou	NULL
,	NULL
T.	NULL
,	NULL
Arao	NULL
,	NULL
S.	NULL
,	NULL
Tashino	NULL
,	NULL
H.	NULL
,	NULL
Okamura	NULL
,	NULL
H.	NULL
,	NULL
Nomore	NULL
,	NULL
H.	NULL
,	NULL
Hiai	NULL
,	NULL
H.	NULL
&	NULL
Fukamoto	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

54	NULL
,	NULL
1825-1830	NULL
.	NULL

24	NULL
.	NULL

-	NULL
Halat	NULL
,	NULL
N.	NULL
,	NULL
Keim	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Melhem	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
Zhu	NULL
,	NULL
X.	NULL
X.	NULL
,	NULL
Eckerstrom	NULL
,	NULL
C.	NULL
,	NULL
Brodeur	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Reynolds	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
Leeger	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
Lottsperds	NULL
,	NULL
T.	NULL
,	NULL
Strah-ber	NULL
,	NULL
J.	NULL
R.	NULL
&	NULL
Hanash	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88	NULL
,	NULL
341-345	NULL
.	NULL

25	NULL
.	NULL

Keim	NULL
,	NULL
D.	NULL
,	NULL
Hailat	NULL
,	NULL
N.	NULL
,	NULL
Melhem	NULL
,	NULL
R.	NULL
,	NULL
Zhu	NULL
,	NULL
X.	NULL
X.	NULL
,	NULL
Lascu	NULL
,	NULL
L.	NULL
,	NULL
Veron	NULL
,	NULL
M.	NULL
,	NULL
Strahler	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Hanash	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

89	NULL
,	NULL
919-924	NULL
.	NULL

26	NULL
.	NULL

-	NULL
Okabe-Kado	NULL
,	NULL
J.	NULL
,	NULL
Kosukabe	NULL
,	NULL
T.	NULL
,	NULL
Honma	NULL
,	NULL
Y.	NULL
,	NULL
Hayashi	NULL
,	NULL
M.	NULL
,	NULL
Henzel	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

&	NULL
Hozumi	NULL
,	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

182	NULL
,	NULL
987-994	NULL
.	NULL

27	NULL
.	NULL

-	NULL
Yamashiro	NULL
,	NULL
S.	NULL
,	NULL
Urano	NULL
,	NULL
T.	NULL
,	NULL
Shiku	NULL
,	NULL
H.	NULL
&	NULL
Furukawa	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Oncogene	NULL
9	NULL
,	NULL
2461-2468	NULL
.	NULL

28	NULL
.	NULL

-	NULL
Morishita	NULL
,	NULL
K.	NULL
,	NULL
Parganes	NULL
,	NULL
E.	NULL
,	NULL
Matsugi	NULL
,	NULL
T.	NULL
&	NULL
Thile	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
183-189	NULL
.	NULL

29	NULL
.	NULL

-	NULL
Rovera	NULL
,	NULL
G.	NULL
,	NULL
Valtieri	NULL
,	NULL
M.	NULL
,	NULL
Mavilio	NULL
,	NULL
F.	NULL
&	NULL
Reddy	NULL
,	NULL
E.	NULL
P.	NULL
(	NULL
1987	NULL
)	NULL
Oncogene	NULL
1	NULL
,	NULL
24-35	NULL
.	NULL

30	NULL
.	NULL

Laneuville	NULL
,	NULL
P.	NULL
,	NULL
Heisterkamp	NULL
,	NULL
N.	NULL
&	NULL
Groffen	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
275-282	NULL
.	NULL

31	NULL
.	NULL

Gishizky	NULL
,	NULL
H.	NULL
L.	NULL
&	NULL
Witte	NULL
,	NULL
D.	NULL
N.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
256	NULL
,	NULL
836-839	NULL
.	NULL

32	NULL
.	NULL

Daley	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Van	NULL
Litten	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

&	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1990	NULL
)	NULL
Science	NULL
247	NULL
,	NULL
824-830.	NULL
o	NULL
in	NULL

